Header cover image
  • Investing Ideas
  • Slovenian Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Slovenian Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Results

1

0 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

1 companies

Krka d. d

Market Cap: €7.8b

A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.

KRKG

€257.50

7D

-1.0%

1Y

29.7%